Stay updated on Teriflunomide in Pediatric MS Clinical Trial
Sign up to get notified when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.

Latest updates to the Teriflunomide in Pediatric MS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record is displayed instead of a 403 Forbidden page, showing study details, outcomes, locations, publications, and study documents.SummaryDifference78%

- Check15 days agoChange DetectedThe site footer now displays revision v3.8.0, while the study record page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces updates to NIH websites and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during a transition.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now renders a 403 Forbidden error with a Home link, replacing the full study record content and effectively removing the detailed trial information from view.SummaryDifference18%

Stay in the know with updates to Teriflunomide in Pediatric MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.